{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T21:39:04Z","timestamp":1792791544435,"version":"4.5.0"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2011,12,1]],"date-time":"2011-12-01T00:00:00Z","timestamp":1322697600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Respir Res"],"published-print":{"date-parts":[[2011,12]]},"DOI":"10.1186\/1465-9921-12-156","type":"journal-article","created":{"date-parts":[[2011,12,7]],"date-time":"2011-12-07T21:26:31Z","timestamp":1323293191000},"source":"Crossref","is-referenced-by-count":119,"title":["Efficacy and safety of once-daily NVA237 in patients with moderate-to-severe COPD: the GLOW1 trial"],"prefix":"10.1186","volume":"12","author":[{"given":"Anthony","family":"D'Urzo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gary T","family":"Ferguson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan A","family":"van Noord","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuto","family":"Hirata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmen","family":"Martin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachael","family":"Horton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yimeng","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donald","family":"Banerji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tim","family":"Overend","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2011,12,31]]},"reference":[{"key":"1182_CR1","volume-title":"Global strategy for diagnosis, management and prevention of COPD","author":"GOLD","year":"2010","unstructured":"GOLD: Global strategy for diagnosis, management and prevention of COPD. 2010, [ http:\/\/www.goldcopd.com\/ ]"},{"key":"1182_CR2","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1183\/09031936.00082507","volume":"30","author":"G Viegi","year":"2007","unstructured":"Viegi G, Pistelli F, Sherrill DL, Maio S, Baldacci S, Carrozzi L: Definition, epidemiology and natural history of COPD. Eur Respir J. 2007, 30: 993-1013. 10.1183\/09031936.00082507.","journal-title":"Eur Respir J"},{"key":"1182_CR3","doi-asserted-by":"publisher","first-page":"397","DOI":"10.2147\/COPD.S4802","volume":"4","author":"S Kesten","year":"2009","unstructured":"Kesten S, Celli B, Decramer M, Leimer I, Tashkin D: Tiotropium HandiHaler in the treatment of COPD: a safety review. Int J Chron Obstruct Pulmon Dis. 2009, 4: 397-409.","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"key":"1182_CR4","doi-asserted-by":"publisher","first-page":"1294","DOI":"10.1378\/chest.118.5.1294","volume":"118","author":"R Casaburi","year":"2000","unstructured":"Casaburi R, Briggs DD, Donohue JF, Serby CW, Menjoge SS, Witek TJ: The spirometric efficacy of once-daily dosing with tiotropium in stable COPD: a 13-week multicenter trial. The US Tiotropium Study Group. Chest. 2000, 118: 1294-1302. 10.1378\/chest.118.5.1294.","journal-title":"Chest"},{"key":"1182_CR5","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1159\/000063278","volume":"69","author":"KM Beeh","year":"2002","unstructured":"Beeh KM, Welte T, Buhl R: Anticholinergics in the treatment of chronic obstructive pulmonary disease. Respiration. 2002, 69: 372-379. 10.1159\/000063278.","journal-title":"Respiration"},{"key":"1182_CR6","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1016\/j.rmed.2010.10.021","volume":"105","author":"C Fogarty","year":"2011","unstructured":"Fogarty C, Hattersley H, Di SL, Drollmann A: Bronchodilatory effects of NVA237, a once daily long-acting muscarinic antagonist, in COPD patients. Respir Med. 2011, 105: 337-342. 10.1016\/j.rmed.2010.10.021.","journal-title":"Respir Med"},{"key":"1182_CR7","doi-asserted-by":"publisher","first-page":"1482","DOI":"10.1016\/j.rmed.2010.04.006","volume":"104","author":"C Verkindre","year":"2010","unstructured":"Verkindre C, Fukuchi Y, Flemale A, Takeda A, Overend T, Prasad N, Dolker M: Sustained 24-h efficacy of NVA237, a once-daily long-acting muscarinic antagonist, in COPD patients. Respir Med. 2010, 104: 1482-1489. 10.1016\/j.rmed.2010.04.006.","journal-title":"Respir Med"},{"key":"1182_CR8","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1016\/j.pupt.2010.04.005","volume":"23","author":"C Vogelmeier","year":"2010","unstructured":"Vogelmeier C, Verkindre C, Cheung D, Galdiz JB, Guclu SZ, Spangenthal S, Overend T, Henley M, Mizutani G, Zeldin RK: Safety and tolerability of NVA237, a once-daily long-acting muscarinic antagonist, in COPD patients. Pulm Pharmacol Ther. 2010, 23: 438-444. 10.1016\/j.pupt.2010.04.005.","journal-title":"Pulm Pharmacol Ther"},{"key":"1182_CR9","volume-title":"Global Strategy for the diagnosis, management and prevention of COPD","author":"GOLD","year":"2008","unstructured":"GOLD: Global Strategy for the diagnosis, management and prevention of COPD. 2008, [ http:\/\/www.goldcopd.com\/ ]"},{"key":"1182_CR10","volume-title":"Declaration of Helsinki-ethical principals for medical research involving human subjects","author":"World Medical Association","year":"2008","unstructured":"World Medical Association: Declaration of Helsinki-ethical principals for medical research involving human subjects. 2008"},{"key":"1182_CR11","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1183\/09031936.05.00034805","volume":"26","author":"MR Miller","year":"2005","unstructured":"Miller MR, Hankinson J, Brusasco V, Burgos F, Casaburi R, Coates A, Crapo R, Enright P, van der Grinten CP, Gustafsson P, Jensen R, Johnson DC, MacIntyre N, McKay R, Navajas D, Pedersen OF, Pellegrino R, Viegi G, Wanger J: Standardisation of spirometry. Eur Respir J. 2005, 26: 319-338. 10.1183\/09031936.05.00034805.","journal-title":"Eur Respir J"},{"key":"1182_CR12","doi-asserted-by":"publisher","first-page":"196","DOI":"10.7326\/0003-4819-106-2-196","volume":"106","author":"NR Anthonisen","year":"1987","unstructured":"Anthonisen NR, Manfreda J, Warren CPW, Hershfield ES, Harding GK, Nelson NA: Antibiotic therapy in exacerbations of chronic obstructive pulmonary disease. Ann Intern Med. 1987, 106: 196-204.","journal-title":"Ann Intern Med"},{"key":"1182_CR13","doi-asserted-by":"publisher","first-page":"1418","DOI":"10.1164\/ajrccm.157.5.9709032","volume":"157","author":"TAR Seemungal","year":"1998","unstructured":"Seemungal TAR, Donaldson GC, Paul EA, Bestall JC, Jeffries DJ, Wedzicha JA: Effect of exacerbation on quality of life in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 1998, 157: 1418-1422.","journal-title":"Am J Respir Crit Care Med"},{"key":"1182_CR14","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1183\/09031936.03.00068503a","volume":"21","author":"TJ Witek Jr","year":"2003","unstructured":"Witek TJ, Mahler DA: Minimal important difference of the transition dyspnoea index in a multinational clinical trial. Eur Respir J. 2003, 21: 267-272. 10.1183\/09031936.03.00068503a.","journal-title":"Eur Respir J"},{"issue":"Suppl B","key":"1182_CR15","doi-asserted-by":"publisher","first-page":"S11","DOI":"10.1016\/j.rmed.2005.09.011","volume":"99","author":"P Jones","year":"2005","unstructured":"Jones P, Lareau S, Mahler DA: Measuring the effects of COPD on the patient. Respir Med. 2005, 99 (Suppl B): S11-S18.","journal-title":"Respir Med"},{"key":"1182_CR16","first-page":"95","volume":"2","author":"KL Rice","year":"2007","unstructured":"Rice KL, Kunisaki KM, Niewoehner DE: Role of tiotropium in the treatment of COPD. Int J Chron Obstruct Pulmon Dis. 2007, 2: 95-105.","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"key":"1182_CR17","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1038\/sj.bjp.0702573","volume":"127","author":"EB Haddad","year":"1999","unstructured":"Haddad EB, Patel H, Keeling JE, Yacoub MH, Barnes PJ, Belvisi MG: Pharmacological characterization of the muscarinic receptor antagonist, glycopyrrolate, in human and guinea-pig airways. Br J Pharmacol. 1999, 127: 413-420. 10.1038\/sj.bjp.0702573.","journal-title":"Br J Pharmacol"},{"key":"1182_CR18","doi-asserted-by":"publisher","first-page":"1128","DOI":"10.1056\/NEJMoa0909883","volume":"363","author":"JR Hurst","year":"2010","unstructured":"Hurst JR, Vestbo J, Anzueto A, Locantore N, M\u00fcllerova H, Tal-Singer R, Miller B, Lomas DA, Agusti A, Macnee W, Calverley P, Rennard S, Wouters EF, Wedzicha JA: Susceptibility to exacerbation in chronic obstructive pulmonary disease. N Engl J Med. 2010, 363: 1128-1138. 10.1056\/NEJMoa0909883.","journal-title":"N Engl J Med"},{"key":"1182_CR19","doi-asserted-by":"publisher","first-page":"203","DOI":"10.2147\/COPD.S3385","volume":"4","author":"TA Seemungal","year":"2009","unstructured":"Seemungal TA, Hurst JR, Wedzicha JA: Exacerbation rate, health status and mortality in COPD--a review of potential interventions. Int J Chron Obstruct Pulmon Dis. 2009, 4: 203-223.","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"key":"1182_CR20","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1055\/s-2005-919145","volume":"60","author":"KM Beeh","year":"2006","unstructured":"Beeh KM, Beier J, Buhl R, Stark-Lorenzen P, Gerken F, Metzdorf N: Efficacy of tiotropium bromide (Spiriva) in patients with chronic-obstructive pulmonary disease (COPD) of different severities. Pneumologie. 2006, 60: 341-346. 10.1055\/s-2005-919145.","journal-title":"Pneumologie"},{"key":"1182_CR21","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1183\/09031936.02.00269802","volume":"19","author":"R Casaburi","year":"2002","unstructured":"Casaburi R, Mahler DA, Jones PW, Wanner A, San PG, ZuWallack RL, Menjoge SS, Serby CW, Witek T: A long-term evaluation of once-daily inhaled tiotropium in chronic obstructive pulmonary disease. Eur Respir J. 2002, 19: 217-224. 10.1183\/09031936.02.00269802.","journal-title":"Eur Respir J"},{"key":"1182_CR22","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1155\/2007\/192961","volume":"14","author":"CK Chan","year":"2007","unstructured":"Chan CK, Maltais F, Sigouin C, Haddon JM, Ford GT: A randomized controlled trial to assess the efficacy of tiotropium in Canadian patients with chronic obstructive pulmonary disease. Can Respir J. 2007, 14: 465-472.","journal-title":"Can Respir J"},{"key":"1182_CR23","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1186\/1465-9921-8-45","volume":"8","author":"D Freeman","year":"2007","unstructured":"Freeman D, Lee A, Price D: Efficacy and safety of tiotropium in COPD patients in primary care--the SPiRiva Usual CarE (SPRUCE) study. Respir Res. 2007, 8: 45-10.1186\/1465-9921-8-45.","journal-title":"Respir Res"},{"key":"1182_CR24","doi-asserted-by":"publisher","first-page":"169","DOI":"10.3132\/pcrj.2008.00037","volume":"17","author":"G Johansson","year":"2008","unstructured":"Johansson G, Lindberg A, Romberg K, Nordstrom L, Gerken F, Roquet A: Bronchodilator efficacy of tiotropium in patients with mild to moderate COPD. Prim Care Respir J. 2008, 17: 169-175. 10.3132\/pcrj.2008.00037.","journal-title":"Prim Care Respir J"},{"key":"1182_CR25","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1016\/j.pupt.2007.04.003","volume":"21","author":"J Moita","year":"2008","unstructured":"Moita J, Barbara C, Cardoso J, Costa R, Sousa M, Ruiz J, Santos ML: Tiotropium improves FEV1 in patients with COPD irrespective of smoking status. Pulm Pharmacol Ther. 2008, 21: 146-151. 10.1016\/j.pupt.2007.04.003.","journal-title":"Pulm Pharmacol Ther"},{"key":"1182_CR26","doi-asserted-by":"publisher","first-page":"317","DOI":"10.7326\/0003-4819-143-5-200509060-00007","volume":"143","author":"DE Niewoehner","year":"2005","unstructured":"Niewoehner DE, Rice K, Cote C, Paulson D, Cooper JA, Korducki L, Cassino C, Kesten S: Prevention of exacerbations of chronic obstructive pulmonary disease with tiotropium, a once-daily inhaled anticholinergic bronchodilator: a randomized trial. Ann Intern Med. 2005, 143: 317-326.","journal-title":"Ann Intern Med"},{"key":"1182_CR27","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1159\/000089655","volume":"73","author":"C Verkindre","year":"2006","unstructured":"Verkindre C, Bart F, Aguilaniu B, Fortin F, Guerin JC, Le MC, Iacono P, Huchon G: The effect of tiotropium on hyperinflation and exercise capacity in chronic obstructive pulmonary disease. Respiration. 2006, 73: 420-427. 10.1159\/000089655.","journal-title":"Respiration"},{"key":"1182_CR28","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1136\/thorax.58.5.399","volume":"58","author":"V Brusasco","year":"2003","unstructured":"Brusasco V, Hodder R, Miravitlles M, Korducki L, Towse L, Kesten S: Health outcomes following treatment for six months with once daily tiotropium compared with twice daily salmeterol in patients with COPD. Thorax. 2003, 58: 399-404. 10.1136\/thorax.58.5.399.","journal-title":"Thorax"},{"key":"1182_CR29","doi-asserted-by":"publisher","first-page":"1543","DOI":"10.1056\/NEJMoa0805800","volume":"359","author":"DP Tashkin","year":"2008","unstructured":"Tashkin DP, Celli B, Senn S, Burkhart D, Kesten S, Menjoge S, Decramer M: A 4-year trial of tiotropium in chronic obstructive pulmonary disease. N Engl J Med. 2008, 359: 1543-1554. 10.1056\/NEJMoa0805800.","journal-title":"N Engl J Med"},{"key":"1182_CR30","doi-asserted-by":"crossref","first-page":"301","DOI":"10.2147\/COPD.S2463","volume":"3","author":"AB Tonnel","year":"2008","unstructured":"Tonnel AB, Perez T, Grosbois JM, Verkindre C, Bravo ML, Brun M: Effect of tiotropium on health-related quality of life as a primary efficacy endpoint in COPD. Int J Chron Obstruct Pulmon Dis. 2008, 3: 301-310.","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"key":"1182_CR31","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1056\/NEJMoa1008378","volume":"364","author":"C Vogelmeier","year":"2011","unstructured":"Vogelmeier C, Hederer B, Glaab T, Schmidt H, Rutten-van M\u00f6lken MP, Beeh KM, Rabe KF, Fabbri LM, POET-COPD Investigators: Tiotropium versus salmeterol for the prevention of exacerbations of COPD. N Engl J Med. 2011, 364: 1093-1103. 10.1056\/NEJMoa1008378.","journal-title":"N Engl J Med"},{"key":"1182_CR32","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1136\/thorax.55.4.289","volume":"55","author":"JA van Noord","year":"2000","unstructured":"van Noord JA, Bantje TA, Eland ME, Korducki L, Cornelissen PJ: A randomised controlled comparison of tiotropium and ipratropium in the treatment of chronic obstructive pulmonary disease. The Dutch Tiotropium Study Group. Thorax. 2000, 55: 289-284. 10.1136\/thorax.55.4.289.","journal-title":"Thorax"},{"key":"1182_CR33","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1038\/sj.bjp.0706780","volume":"148","author":"P Abrams","year":"2006","unstructured":"Abrams P, Andersson KE, Buccafusco JJ, Chapple C, de Groat WC, Fryer AD, Kay G, Laties A, Nathanson NM, Pasricha PJ, Wein AJ: Muscarinic receptors: their distribution and function in body systems, and the implications for treating overactive bladder. Br J Pharmacol. 2006, 148: 565-578. 10.1038\/sj.bjp.0706780.","journal-title":"Br J Pharmacol"},{"key":"1182_CR34","first-page":"A117","volume":"3","author":"N Cooper","year":"2006","unstructured":"Cooper N, Walker I, Knowles I: NVA237 and tiotropium bromide demonstrate similar efficacy in an anesthetized rabbit model of methacholine-induced bronchoconstriction. NVA237 demonstrates a reduced systemic pharmacological effect on cardiovascular parameters [abstract]. Proc Am Thoracic Soc. 2006, 3: A117-","journal-title":"Proc Am Thoracic Soc"},{"key":"1182_CR35","doi-asserted-by":"crossref","first-page":"530a","DOI":"10.1378\/chest.132.4_MeetingAbstracts.530a","volume":"132","author":"N Trifilieff Cope","year":"2007","unstructured":"Trifilieff Cope N, Bohacek B, Mazzoni L, Collingwood S: The inhaled antimuscarinic receptor antagonist, NVA237 (glycopyrrolate), has a favorable side-effect profile in a Brown Norway rat lung function model when compared with tiotropium [abstract]. Chest. 2007, 132: 530a-","journal-title":"Chest"},{"key":"1182_CR36","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1034\/j.1399-3003.2000.16b14.x","volume":"16","author":"O Diaz","year":"2000","unstructured":"Diaz O, Villafranca C, Ghezzo H, Borzone G, Leiva A, Milic-Emil J, Lisboa C: Role of inspiratory capacity on exercise tolerance in COPD patients with and without tidal expiratory flow limitation at rest. Eur Respir J. 2000, 16: 269-275. 10.1034\/j.1399-3003.2000.16b14.x.","journal-title":"Eur Respir J"},{"key":"1182_CR37","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1164\/ajrccm.153.3.8630581","volume":"153","author":"MJ Belman","year":"1996","unstructured":"Belman MJ, Botnick WC, Shin JW: Inhaled bronchodilators reduce dynamic hyperinflation during exercise in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 1996, 153: 967-975.","journal-title":"Am J Respir Crit Care Med"}],"container-title":["Respiratory Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1465-9921-12-156.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1465-9921-12-156\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1465-9921-12-156.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,20]],"date-time":"2017-06-20T10:58:07Z","timestamp":1497956287000},"score":1,"resource":{"primary":{"URL":"http:\/\/respiratory-research.biomedcentral.com\/articles\/10.1186\/1465-9921-12-156"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,12]]},"references-count":37,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2011,12]]}},"alternative-id":["1182"],"URL":"https:\/\/doi.org\/10.1186\/1465-9921-12-156","relation":{},"ISSN":["1465-993X"],"issn-type":[{"value":"1465-993X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,12]]},"article-number":"156"}}